Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity NBIX - Neurocrine Biosciences, Inc.
3.72 B
LAST VALUE
25.30%
2 YEAR CAGR
23.28%
5 YEAR CAGR
31.36%
10 YEAR CAGR